Literature DB >> 32498779

Breast Cancer Risk Assessment: A Step-Wise Approach for Primary Care Providers on the Front Lines of Shared Decision Making.

Adelaide H McClintock1, Anna L Golob2, Mary B Laya3.   

Abstract

Breast cancer-screening guidelines increasingly recommend that clinicians perform a risk assessment for breast cancer to inform shared decision making for screening. Precision medicine is quickly becoming the preferred approach to cancer screening, with the aim of increased surveillance in high-risk women, while sparing lower-risk women the burden of unnecessary imaging. Risk assessment also informs clinical care by refining screening recommendations for younger women, identifying women who should be referred to genetic counseling, and identifying candidates for risk-reducing medications. Several breast cancer risk-assessment models are currently available to help clinicians categorize a woman's risk for breast cancer. However, choosing the appropriate model for a given patient requires a working knowledge of the strengths, weaknesses, and performance characteristics of each. The aim of this article is to provide a stepwise approach for clinicians to assess an individual woman's risk for breast cancer and describe the features, appropriate use, and performance characteristics of commonly encountered risk-prediction models. This approach will help primary care providers engage in shared decision making by efficiently generating an accurate risk assessment and make clear, evidence-based screening and prevention recommendations that are appropriately matched to a woman's risk for breast cancer.
Copyright © 2020 Mayo Foundation for Medical Education and Research. All rights reserved.

Entities:  

Year:  2020        PMID: 32498779     DOI: 10.1016/j.mayocp.2020.04.017

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.

Authors:  Debra T Linfield; Michael B Rothberg; Elizabeth R Pfoh; Ryan Noss; Lydia Cassard; Joseph C Powers; Laura Lipold; Kathryn A Martinez
Journal:  Breast Cancer Res Treat       Date:  2022-07-16       Impact factor: 4.624

2.  Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.

Authors:  Guoqiao Zheng; Jan Sundquist; Kristina Sundquist; Jianguang Ji
Journal:  BMC Cancer       Date:  2021-11-12       Impact factor: 4.430

3.  Aberrant epigenetic and transcriptional events associated with breast cancer risk.

Authors:  Natascia Marino; Rana German; Ram Podicheti; Douglas B Rusch; Pam Rockey; Jie Huang; George E Sandusky; Constance J Temm; Sandra Althouse; Kenneth P Nephew; Harikrishna Nakshatri; Jun Liu; Ashley Vode; Sha Cao; Anna Maria V Storniolo
Journal:  Clin Epigenetics       Date:  2022-02-09       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.